Suppr超能文献

新冠疫情对德国诺如病毒传播的影响。

Impact of the COVID-19 pandemic on norovirus circulation in Germany.

机构信息

Consultant Laboratory for Norovirus, Department of Infectious Diseases, Robert Koch Institute, 13353 Berlin, Germany.

Department of Infectious Disease Epidemiology, Robert Koch Institute, 13353 Berlin, Germany.

出版信息

Int J Med Microbiol. 2024 Mar;314:151600. doi: 10.1016/j.ijmm.2024.151600. Epub 2024 Jan 18.

Abstract

Human norovirus is a major cause of viral gastroenteritis in all age groups. The virus is constantly and rapidly changing, allowing mutations and recombination events to create great diversity of circulating viruses. With the start of the COVID-19 pandemic in 2020, a wide range of public health measures were introduced worldwide to control human-to-human transmission of SARS-CoV-2. In Germany, control measures such as distance rules, contact restrictions, personal protection equipment as well as intensive hand hygiene were introduced. To better understand the effect of the measures to control the COVID-19 pandemic on incidence and the molecular epidemiological dynamics of norovirus outbreaks in Germany, we analyzed national notification data between July 2017 and December 2022 and characterized norovirus sequences circulating between January 2018 and December 2022. Compared to a reference period before the pandemic, the incidence of notified norovirus gastroenteritis decreased by 89.7% to 9.6 per 100,000 during the 2020/2021 norovirus season, corresponding to an incidence rate ratio (IRR) of 0.10. Samples from 539 outbreaks were genotyped in two regions of the viral genome from pre-pandemic (January 2018 to February 2020) and samples from 208 outbreaks during pandemic time period (March 2020 to December 2022). As expected, norovirus outbreaks were mainly found in child care facilities and nursing homes. In total, 36 genotypes were detected in the study period. A high proportion of recombinant strains (86%) was found in patients, the proportion of detected recombinant viruses did not vary between the pre-pandemic and pandemic phase. The proportion of the predominant recombinant strain GII.4 Sydney[P16] was unchanged before pandemic and during pandemic at 37.5%. The diversity of most common genotypes in nursing homes and child care facilities showed a different proportion of genotypes causing outbreaks. In nursing homes as well as in child care facilities GII.4 Sydney[P16] was predominant during the whole study period. Compared to the nursing homes, a greater variety of genotypes at the expense of GII.4 Sydney[P16] was detected in child care facilities. Furthermore, the overall proportion of recombinant strain GII.3[P12] increased during the pandemic, due to outbreaks in child care facilities. The COVID-19 pandemic had a high impact on the occurrence of sporadic cases and norovirus outbreaks in Germany, leading to a near suppression of the typical norovirus winter season following the start of the pandemic. The number of norovirus-associated outbreak samples sent to the Consultant Laboratory dropped by 63% during the pandemic. We could not identify a clear influence on circulating norovirus genotypes. The dominance of GII.4 Sydney recombinant strains was independent from the pandemic. Further studies are needed to follow up on the diversity of less predominant genotypes to see if the pandemic could have acted as a bottleneck to the spread of previously minoritized genotypes like GII.3[P12].

摘要

人类诺如病毒是所有年龄段人群病毒性肠胃炎的主要病因。该病毒不断且迅速发生变化,允许突变和重组事件产生大量循环病毒的多样性。随着 2020 年 COVID-19 大流行的开始,全球范围内采取了广泛的公共卫生措施来控制 SARS-CoV-2 的人际传播。在德国,引入了距离规则、接触限制、个人防护设备以及强化手部卫生等控制措施。为了更好地了解控制 COVID-19 大流行的措施对德国诺如病毒暴发的发病率和分子流行病学动态的影响,我们分析了 2017 年 7 月至 2022 年 12 月的全国通报数据,并对 2018 年 1 月至 2022 年 12 月期间循环的诺如病毒序列进行了特征分析。与大流行前的参考期相比,2020/2021 诺如病毒季节的通知性诺如病毒肠胃炎发病率下降了 89.7%,至每 100,000 人 9.6 例,发病率比值(IRR)为 0.10。从大流行前(2018 年 1 月至 2020 年 2 月)和大流行期间(2020 年 3 月至 2022 年 12 月)的两个病毒基因组区域对 539 个暴发的样本进行了基因分型。如预期的那样,诺如病毒暴发主要发生在儿童保育设施和疗养院。在研究期间共检测到 36 种基因型。在患者中发现了高比例的重组株(86%),在大流行前和大流行期间检测到的重组病毒比例没有差异。主要重组株 GII.4 Sydney[P16]的比例在大流行前和大流行期间保持不变,为 37.5%。疗养院和儿童保育设施中最常见基因型的多样性显示出导致暴发的基因型比例不同。在整个研究期间,GII.4 Sydney[P16]在疗养院和儿童保育设施中均占主导地位。与疗养院相比,在儿童保育设施中检测到的导致暴发的基因型种类更多,而 GII.4 Sydney[P16]的比例则较低。此外,由于儿童保育设施暴发,大流行期间重组株 GII.3[P12]的总体比例增加。COVID-19 大流行对德国散发性病例和诺如病毒暴发的发生产生了重大影响,导致大流行开始后,典型的诺如病毒冬季季节几乎被抑制。大流行期间,送往顾问实验室的诺如病毒相关暴发样本数量减少了 63%。我们无法确定循环诺如病毒基因型是否受到明显影响。GII.4 Sydney 重组株的优势与大流行无关。需要进一步的研究来跟踪研究不太主要的基因型的多样性,以了解 COVID-19 大流行是否可能成为先前次要基因型(如 GII.3[P12])传播的瓶颈。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验